Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes
- PMID: 8977340
- PMCID: PMC1383308
- DOI: 10.1136/gut.39.2.255
Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes
Abstract
Background: The molecular mechanisms mediating the antiproliferative effects of interferon alpha on human pancreatic carcinoma cells are poorly understood.
Aim: To characterise the effects of interferon alpha on protein kinase C isoenzyme expression in interferon alpha sensitive and resistant human pancreatic tumour cell lines.
Methods: The ductal human pancreatic carcinoma cell lines Capan 1 and Capan 2 were investigated. Anchorage dependent and independent growth was determined by cell number and a human tumour clonogenic assay. Interferon alpha receptor expression was examined by reverse-transcriptase polymerase chain reaction and electrophoretic mobility shift assay. Protein kinase C isoenzyme expression was evaluated by western blotting using monospecific polyclonal antibodies.
Results: Interferon alpha treatment results in a time and dose dependent inhibition of anchorage dependent and independent growth in Capan 1 cells while Capan 2 cells were not affected by interferon alpha. Both cell lines express interferon alpha receptor mRNA transcripts. Growth inhibition by interferon alpha in Capan 1 cells was paralleled by a profound decrease of protein kinase C alpha and zeta expression while these isoenzymes were unaffected in the interferon resistant cell line Capan 2.
Conclusion: Inhibition of protein kinase C isoenzyme expression might determine the sensitivity of a given pancreatic carcinoma to respond to the antiproliferative action of interferon alpha.
Similar articles
-
Differential growth regulation by all-trans retinoic acid is determined by protein kinase C alpha in human pancreatic carcinoma cells.Endocrinology. 1996 Aug;137(8):3340-7. doi: 10.1210/endo.137.8.8754760. Endocrinology. 1996. PMID: 8754760
-
Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-alpha.Br J Cancer. 1996 Aug;74(3):394-9. doi: 10.1038/bjc.1996.371. Br J Cancer. 1996. PMID: 8695354 Free PMC article.
-
Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms.Ann Surg Oncol. 1996 Nov;3(6):564-9. doi: 10.1007/BF02306090. Ann Surg Oncol. 1996. PMID: 8915489
-
Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.Clin Cancer Res. 2001 Jan;7(1):105-12. Clin Cancer Res. 2001. PMID: 11205897
-
Enhancement of anchorage-independent growth of human pancreatic carcinoma MIA PaCa-2 cells by signaling from protein kinase C to mitogen-activated protein kinase.Mol Carcinog. 2002 Aug;34(4):180-6. doi: 10.1002/mc.10063. Mol Carcinog. 2002. PMID: 12203369
Cited by
-
TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells.Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G899-905. doi: 10.1152/ajpgi.00411.2007. Epub 2008 Jan 31. Am J Physiol Gastrointest Liver Physiol. 2008. PMID: 18239055 Free PMC article.
-
Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis.Gut. 2001 Aug;49(2):251-62. doi: 10.1136/gut.49.2.251. Gut. 2001. PMID: 11454803 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical